Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Ultrasonic surgical aspirator devices use an oscillating tip to cause tissue fragmentation through the delivery of ultrasound energy to target tissue. the potential for tissue dissemination is mitigated but not completely eliminated by the use of suction/aspiration. industry-wide ifu update initiated by the fda. adding the contraindication: this ultrasonic surgical aspirator device is not indicated for and should not be used for the fragmentation emulsification and aspiration of uterine fibroids.